Identification of Distinct Immune Cell Subsets Associated With Asymptomatic Infection, Disease Severity, and Viral Persistence in COVID-19 Patients
The cell-mediated protective and pathogenic immune responses to SARS-CoV-2 infection remain largely elusive. Here we identified 76 distinct cell subsets in the PBMC samples that were associated with various clinical presentations of COVID-19 using scRNA-seq technology coupled with a deep and compreh...
Saved in:
Published in | Frontiers in immunology Vol. 13; p. 812514 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
22.02.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The cell-mediated protective and pathogenic immune responses to SARS-CoV-2 infection remain largely elusive. Here we identified 76 distinct cell subsets in the PBMC samples that were associated with various clinical presentations of COVID-19 using scRNA-seq technology coupled with a deep and comprehensive analysis of unique cell surface markers and differentially expressed genes. We revealed that (TRAV1-2
+
CD8
+
)MAIT cells and (NCAM1
hi
CD160
+
)NK cells significantly enriched in the asymptomatic subjects whereas (LAG3
+
CD160
+
CD8
+
)NKT cells increased in the symptomatic patients. We also observed that (CD68
-
CSF1R
-
IL1B
hi
CD14
+
)classical monocytes were positively correlated with the disease severity. Moreover, (CD33
-
HLA-DMA
-
CD14
+
)classical monocytes and (CLEC10A
-
S100A9
lo
)pDC were associated with the viral persistence. The GO and KEGG analyses identified enriched pathways related to immune responses, inflammation, and apoptosis. These findings may enhance our understanding of the immunopathogenesis of COVID-19 and help develop novel strategies against SARS-CoV-2 infection. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by: Tram Pham, Montreal Clinical Research Institute (IRCM), Canada Lead Contact Reviewed by: James E. Thaventhiran, University of Cambridge, United Kingdom; Martina Severa, National Institute of Health (ISS), Italy These authors have contributed equally to this work and share the first authorship This article was submitted to Viral Immunology, a section of the journal Frontiers in Immunology |
ISSN: | 1664-3224 1664-3224 |
DOI: | 10.3389/fimmu.2022.812514 |